PFE vs. LX
PFE (Pfizer Inc.) and LX (LexinFintech Holdings Ltd.) are both stocks. PFE operates in Drug Manufacturers - General (Healthcare), while LX operates in Credit Services (Financial Services). Over the past 5 years, PFE returned -3.62%/yr vs -25.63%/yr for LX. At a 0.12 correlation, their price movements are largely independent.
Performance
PFE vs. LX - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, PFE achieves a 6.34% return, which is significantly higher than LX's -31.09% return.
PFE
- 1D
- -1.61%
- 1M
- -0.23%
- YTD
- 6.34%
- 6M
- 2.75%
- 1Y
- 17.39%
- 3Y*
- -7.47%
- 5Y*
- -3.62%
- 10Y*
- 1.79%
LX
- 1D
- 0.00%
- 1M
- -0.96%
- YTD
- -31.09%
- 6M
- -31.51%
- 1Y
- -68.23%
- 3Y*
- 4.91%
- 5Y*
- -25.63%
- 10Y*
- —
PFE vs. LX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
PFE Pfizer Inc. | 6.34% | 0.65% | -2.22% | -41.26% | -10.41% | 66.70% | 3.07% | -6.91% | 24.82% | -0.06% |
LX LexinFintech Holdings Ltd. | -31.09% | -40.97% | 242.61% | 6.40% | -50.78% | -42.39% | -51.76% | 91.59% | -47.84% | 1,199.07% |
Correlation
The correlation between PFE and LX is 0.19, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.19 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.12 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.08 |
Correlation (All Time) Calculated using the full available price history since Dec 22, 2017 | 0.12 |
The correlation between PFE and LX shifts across timeframes, from 0.08 (5 years) to 0.19 (1 year), reflecting how their relationship changes across market environments.
Fundamentals
PFE:
$146.83B
LX:
$348.44M
PFE:
$1.31
LX:
$8.27
PFE:
19.53
LX:
0.25
PFE:
0.35
LX:
0.05
PFE:
2.31
LX:
0.03
PFE:
1.63
LX:
0.03
PFE:
$63.32B
LX:
$13.33B
PFE:
$43.91B
LX:
$6.95B
PFE:
$16.94B
LX:
$1.74B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
PFE vs. LX — Risk / Return Rank
PFE
LX
PFE vs. LX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Pfizer Inc. (PFE) and LexinFintech Holdings Ltd. (LX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| PFE | LX | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +1.80 | ||
| Sortino ratioReturn per unit of downside risk | +3.28 | ||
| Omega ratioGain probability vs. loss probability | 1.15 | 0.76 | +0.39 |
| Calmar ratioReturn relative to maximum drawdown | 1.52 | -0.95 | +2.47 |
| Martin ratioReturn relative to average drawdown | 3.11 | -1.38 | +4.48 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| PFE | LX | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 0.73 | -1.07 | +1.80 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | -0.14 | -0.35 | +0.21 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.08 | — | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.33 | 0.04 | +0.30 |
Drawdowns
PFE vs. LX - Drawdown Comparison
The maximum PFE drawdown since its inception was -69.24%, smaller than the maximum LX drawdown of -93.19%. Use the drawdown chart below to compare losses from any high point for PFE and LX.
Loading charts...
Drawdown Indicators
| PFE | LX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -69.24% | -93.19% | +23.95% |
Max Drawdown (1Y)Largest decline over 1 year | -11.47% | -72.18% | +60.71% |
Max Drawdown (3Y)Largest decline over 3 years | -40.75% | -81.04% | +40.29% |
Max Drawdown (5Y)Largest decline over 5 years | -58.96% | -90.23% | +31.27% |
Max Drawdown (10Y)Largest decline over 10 years | -58.96% | — | — |
Current DrawdownCurrent decline from peak | -46.90% | -85.24% | +38.34% |
Average DrawdownAverage peak-to-trough decline | -22.89% | -63.32% | +40.43% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 5.61% | 49.57% | -43.96% |
Volatility
PFE vs. LX - Volatility Comparison
The current volatility for Pfizer Inc. (PFE) is 4.78%, while LexinFintech Holdings Ltd. (LX) has a volatility of 22.74%. This indicates that PFE experiences smaller price fluctuations and is considered to be less risky than LX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| PFE | LX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 4.78% | 22.74% | -17.96% |
Volatility (6M)Calculated over the trailing 6-month period | 14.74% | 36.53% | -21.79% |
Volatility (1Y)Calculated over the trailing 1-year period | 23.98% | 63.97% | -39.99% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 25.52% | 73.71% | -48.19% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 23.89% | 323.46% | -299.57% |
Dividends
PFE vs. LX - Dividend Comparison
PFE's dividend yield for the trailing twelve months is around 6.71%, less than LX's 18.45% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
LX LexinFintech Holdings Ltd. | 18.45% | 9.30% | 2.38% | 11.85% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
PFE Pfizer Inc. | 6.71% | 6.91% | 6.33% | 5.70% | 3.12% | 2.64% | 3.92% | 3.68% | 3.12% | 3.53% | 3.69% | 3.47% |
Financials
PFE vs. LX - Financials Comparison
This section allows you to compare key financial metrics between Pfizer Inc. and LexinFintech Holdings Ltd.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
PFE vs. LX - Profitability Comparison
PFE - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Pfizer Inc. reported a gross profit of 9.72B and revenue of 14.45B. Therefore, the gross margin over that period was 67.3%.
LX - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, LexinFintech Holdings Ltd. reported a gross profit of 2.35B and revenue of 3.33B. Therefore, the gross margin over that period was 70.6%.
PFE - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Pfizer Inc. reported an operating income of 4.03B and revenue of 14.45B, resulting in an operating margin of 27.9%.
LX - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, LexinFintech Holdings Ltd. reported an operating income of 328.36M and revenue of 3.33B, resulting in an operating margin of 9.9%.
PFE - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Pfizer Inc. reported a net income of 2.69B and revenue of 14.45B, resulting in a net margin of 18.6%.
LX - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, LexinFintech Holdings Ltd. reported a net income of 200.22M and revenue of 3.33B, resulting in a net margin of 6.0%.
Frequently Asked Questions
PFE and LX have a correlation of 0.19, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
LX has higher volatility (22.74%) compared to PFE (4.78%). In terms of maximum drawdown, PFE dropped -69.24% vs LX's -93.19%.
PFE currently has the higher Sharpe Ratio (0.73 vs -1.07), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for PFE and LX
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer